Senior investor and operating executive with experience in private equity and corporate finance, focused on middle-market buyouts, growth equity and operational value creation. Christopher J. McKinley brings portfolio oversight, M&A execution and capital markets engagement skills, often leading turnaround programs, strategic carve-outs and EBITDA expansion initiatives. Background includes investor relations, deal sourcing and board-level governance; known for disciplined due diligence, hands-on operational improvement and fundraising across institutional limited partners.
Senior investor and operating executive with experience in private equity and corporate finance, focused on middle-market buyouts, growth equity and operational value creation. Christopher J. McKinley brings portfolio oversight, M&A execution and capital markets engagement skills, often leading turnaround programs, strategic carve-outs and EBITDA expansion initiatives. Background includes investor relations, deal sourcing and board-level governance; known for disciplined due diligence, hands-on operational improvement and fundraising across institutional limited partners.
Focuses on value-oriented middle-market private investments, privileging control or significant influence to drive operational turnarounds and EBITDA expansion. Employs rigorous due diligence and conservative capital structuring, blending buyout and growth-equity tactics to underwrite resilient cash flows. Prioritizes strategic carve-outs, repeatable M&A, and active board oversight, using hands-on operating levers to accelerate margin improvement. Time horizon is multi-year with emphasis on capital preservation, clear exit pathways via strategic sale or IPO, and disciplined LP alignment in fundraising.
Focuses on value-oriented middle-market private investments, privileging control or significant influence to drive operational turnarounds and EBITDA expansion. Employs rigorous due diligence and conservative capital structuring, blending buyout and growth-equity tactics to underwrite resilient cash flows. Prioritizes strategic carve-outs, repeatable M&A, and active board oversight, using hands-on operating levers to accelerate margin improvement. Time horizon is multi-year with emphasis on capital preservation, clear exit pathways via strategic sale or IPO, and disciplined LP alignment in fundraising.
| Trades 1298 | Longs Won 912/1298 70% | Profit Factor 14.69 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $551,929.83 |
| Average Win $172,931.39 | Best Trade (Aug 14) $9.68M | Sharpe Ratio -13.23 |
| Average Loss -$27,808.63 | Worst Trade (Sep 01) -$1.07M | Z-Score 14.96 (100%) |
| Commissions $0 | Avg. Trade Length 1y 9m 2w | Expectancy $113,235.2 |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 27,778 | 25,000 | 22,222 | 19,444 | 16,667 | 13,889 | 11,111 | 8,333 | 5,556 | 2,778 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
AAPL Apple Inc. | 8,772 | $1.82M | $2.67M | - | $856,772.95 | 47.13% | -1.087% |
ABBV AbbVie Inc. | 2,979 | $531,572.54 | $738,702.63 | - | $207,130.09 | 38.97% | 0.0 |
ABT Abbott Laboratories | 2,503 | $305,715.56 | $274,629.16 | - | -$31,086.4 | -10.17% | +1.013% |
AGG iShares Core U.S. Aggregate Bond ETF | 36,373 | $3.5M | $3.54M | - | $40,507.03 | 1.16% | 0.0 |
ALL Allstate Corporation | 1,000 | $207,070 | $269,670 | - | $62,600 | 30.23% | 0.0 |
AMZN Amazon.com Inc | 1,492 | $335,473.46 | $406,226.84 | - | $70,753.38 | 21.09% | -2.093% |
AVLV Avantis U.S. Large Cap Value ETF | 66,400 | $6.06M | $6.25M | - | $197,208 | 3.26% | 0.0 |
BCI abrdn Bloomberg All Commodity Strategy K-1 Free ETF | 26,531 | $571,903.84 | $649,744.19 | - | $77,840.35 | 13.61% | 0.0 |
BIL SPDR Bloomberg 1-3 Month T-Bill ETF | 10,197 | $933,631.57 | $932,821.56 | - | -$810.01 | -0.09% | 0.0 |
BKCI BNY Mellon ETF Trust BNY Mellon Concentrated International ETF | 10,458 | $513,844.55 | $577,503.31 | - | $63,658.76 | 12.39% | +0.171% |
BKLC BNY Mellon US Large Cap Core Equity ETF | 22,503 | $607,581 | $1.11M | - | $504,292.23 | 83% | 0.0 |
BND Vanguard Total Bond Market Index Fund | 8,916 | $649,070.12 | $643,289.4 | - | -$5,780.72 | -0.89% | 0.0 |
BRK-A Berkshire Hathaway Inc. | 8 | $5.84M | $6.35M | - | $507,920 | 8.69% | 0.0 |
BRK-B Berkshire Hathaway Inc. | 2,676 | $913,862.66 | $1.42M | - | $502,865.26 | 55.03% | 0.0 |
CGCP Capital Group Core Plus Income ETF | 171,672 | $3.88M | $3.77M | - | -$106,575.53 | -2.75% | 0.0 |
CGMU Capital Group Municipal Income ETF | 223,595 | $6.04M | $6.07M | - | $26,943.84 | 0.45% | 0.0 |
CGXU Capital Group International Focus Equity ETF | 42,192 | $1.06M | $1.46M | - | $407,133.2 | 38.49% | 0.0 |
CSCO Cisco Systems, Inc. | 2,650 | $184,111.67 | $324,810.5 | - | $140,698.83 | 76.42% | 0.0 |
CVX Chevron Corporation | 1,690 | $277,218.96 | $332,355.4 | - | $55,136.44 | 19.89% | +0.898% |
DBMF iMGP DBi Managed Futures Strategy ETF | 8,197 | $247,139 | $256,730.04 | - | $9,591.04 | 3.88% | 0.0 |